Background: PLA2G6-associated neurodegeneration (PLAN) is a recessive neurodegenerative disorder characterized by three distinct phenotypes: infantile neuroaxonal dystrophy (INAD), atypical neuroaxonal dystrophy (atypical NAD), and PLA2G6-related dystonia–parkinsonism. Methods: A consanguineous index case from Turkey was diagnosed with early-onset Parkinsonism at the Istanbul Faculty of Medicine. She and her unaffected brother were subjected to whole-genome sequencing. Results: In this report, we describe a 33-year-old index case with parental consanguinity and early-onset Parkinsonism. Whole-genome sequencing of this individual revealed that a homozygous p.R747W mutation in PLA2G6 segregates with the disease in this family Discussion: T...
Mutations in PLA2G6 were identified in patients with a spectrum of neurodegenerative conditions, suc...
Background and purpose: Mutations in the PLA2G6 gene are causative of PLA2G6-associated neurodegener...
Mutations in PLA2G6 were identified in patients with a spectrum of neurodegenerative conditions, suc...
Background: PLA2G6-associated neurodegeneration (PLAN) is a recessive neurodegenerative disorder cha...
Background:Phospholipase-associated neurodegeneration (PLAN) caused by PLA2G6 mutations is a recessi...
Mutations of PLA2G6 gene are responsible for PARK14, an autosomal recessive L-DOPA responsive dyston...
Mutations of PLA2G6 gene are responsible for PARK14, an autosomal recessive L-DOPA responsive dyston...
BACKGROUND: Complex parkinsonism is the commonest phenotype in late-onset PLA2G6-associated neurodeg...
Phospholipase A2 group VI (PLA2G6)-associated neurodegeneration (PLAN) includes a series of neurodeg...
Background: Complex parkinsonism is the commonest phenotype in late-onset PLA2G6-associated neurodeg...
BACKGROUND: PLA2G6-associated neurodegeneration (PLAN) encompasses infantile- or atypical neuroaxona...
<div><p>Mutations in <i>PLA2G6</i> were identified in patients with a spectrum of neurodegenerative ...
Introduction The phospholipase A2 group VI gene (PLA2G6) encodes an enzyme that catalyzes the hydrol...
BackgroundEarly onset Parkinson's disease (EOPD) is a neurodegenerative disease associated with the ...
Phospholipase A2-associated neurodegeneration (PLAN), a syndrome of Neurodegeneration with Brain Iro...
Mutations in PLA2G6 were identified in patients with a spectrum of neurodegenerative conditions, suc...
Background and purpose: Mutations in the PLA2G6 gene are causative of PLA2G6-associated neurodegener...
Mutations in PLA2G6 were identified in patients with a spectrum of neurodegenerative conditions, suc...
Background: PLA2G6-associated neurodegeneration (PLAN) is a recessive neurodegenerative disorder cha...
Background:Phospholipase-associated neurodegeneration (PLAN) caused by PLA2G6 mutations is a recessi...
Mutations of PLA2G6 gene are responsible for PARK14, an autosomal recessive L-DOPA responsive dyston...
Mutations of PLA2G6 gene are responsible for PARK14, an autosomal recessive L-DOPA responsive dyston...
BACKGROUND: Complex parkinsonism is the commonest phenotype in late-onset PLA2G6-associated neurodeg...
Phospholipase A2 group VI (PLA2G6)-associated neurodegeneration (PLAN) includes a series of neurodeg...
Background: Complex parkinsonism is the commonest phenotype in late-onset PLA2G6-associated neurodeg...
BACKGROUND: PLA2G6-associated neurodegeneration (PLAN) encompasses infantile- or atypical neuroaxona...
<div><p>Mutations in <i>PLA2G6</i> were identified in patients with a spectrum of neurodegenerative ...
Introduction The phospholipase A2 group VI gene (PLA2G6) encodes an enzyme that catalyzes the hydrol...
BackgroundEarly onset Parkinson's disease (EOPD) is a neurodegenerative disease associated with the ...
Phospholipase A2-associated neurodegeneration (PLAN), a syndrome of Neurodegeneration with Brain Iro...
Mutations in PLA2G6 were identified in patients with a spectrum of neurodegenerative conditions, suc...
Background and purpose: Mutations in the PLA2G6 gene are causative of PLA2G6-associated neurodegener...
Mutations in PLA2G6 were identified in patients with a spectrum of neurodegenerative conditions, suc...